Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: ITCI stock price vs VALE: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at VALE's multiple
Needs VALE P/S.
Implied fair value · at ITCI's multiple
Needs ITCI P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ITCI FY 2024 (ended Dec 31, 2024) · VALE FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
11 fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Intra-Cellular Therapies, Inc. · implied price per share
Bear
-$2.92
Base
-$3.43
Bull
-$3.95
VALE S.A. · implied price per share
Bear
$0.81
Base
$0.96
Bull
$1.10
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.19x
0.41x
Net debt / EBITDA
Leverage against operating earnings
9.34x
4.85x
Cash and equivalents
Liquid reserves on the balance sheet
$904.35M
$7.62B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
SUPERNUS PHARMACEUTICALS, INC.
ITCI vs SUPN
ACADIA PHARMACEUTICALS INC
ITCI vs ACAD
Vanda Pharmaceuticals Inc.
ITCI vs VNDA
Sage Therapeutics, Inc.
ITCI vs SAGE
BHP Group Ltd
ITCI vs BHP
FREEPORT-MCMORAN INC
ITCI vs FCX
SOUTHERN COPPER CORP/
ITCI vs SCCO
NEWMONT Corp /DE/
ITCI vs NEM
TECK RESOURCES LTD
ITCI vs TECK
$216.02M
$30.29B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Price unavailable
